exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
$vrtx - - vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress
Stock Market Enthusiast and trying to build a platform to educate investors.